Correlation between Physical Status of Human Papilloma Virus and Cervical Carcinogenesis

The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role of HPV-16 integration in cervi-cal carcinogenesis were investigated.HPV genotyping was performed by using PCR approach with the primer GP5+/G...

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 32; no. 1; pp. 97 - 102
Main Author 李科珍 金鑫 方勇 王常玉 龚妹 陈平波 刘佳 邓东锐 艾继辉
Format Journal Article
LanguageEnglish
Published Heidelberg Huazhong University of Science and Technology 01.02.2012
Subjects
Online AccessGet full text
ISSN1672-0733
1993-1352
DOI10.1007/s11596-012-0017-7

Cover

Abstract The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role of HPV-16 integration in cervi-cal carcinogenesis were investigated.HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women.Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection,includ-ing 112 specimens with cervical cancer,151 specimens with CINⅠ,246 specimens with CINⅡ and 120 specimens with CINⅢ.The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection.The frequency of HPV-16 pure integration was 65.18% (73/112),56.57% (47/120),23.58% (58/246) and 7.95% (12/151) in cervical cancer,CINⅢ,CINⅡand CINⅠ patients respectively.In situ hybridization was performed on some paraffin-embedded sections of CINⅡ,CINⅢ and cervical cancer to verify the physical status of HPV-16 infection.Sig-nificant difference was observed between cervical cancer and CINⅠ,CINⅡ,CINⅢ in the frequency of HPV-16 integration (P0.01).It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer.In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration.The application of testing HPV genotyping and physical status based on detection of HC-Ⅱ HPV DNA would be in favor of predicting the progno-sis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.
AbstractList The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.
The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN II and 120 specimens with CIN III. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CIN III, CIN II and CIN I patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CIN II, CIN III and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CIN II, CIN III in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC- II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.
The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role of HPV-16 integration in cervi-cal carcinogenesis were investigated.HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women.Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection,includ-ing 112 specimens with cervical cancer,151 specimens with CINⅠ,246 specimens with CINⅡ and 120 specimens with CINⅢ.The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection.The frequency of HPV-16 pure integration was 65.18% (73/112),56.57% (47/120),23.58% (58/246) and 7.95% (12/151) in cervical cancer,CINⅢ,CINⅡand CINⅠ patients respectively.In situ hybridization was performed on some paraffin-embedded sections of CINⅡ,CINⅢ and cervical cancer to verify the physical status of HPV-16 infection.Sig-nificant difference was observed between cervical cancer and CINⅠ,CINⅡ,CINⅢ in the frequency of HPV-16 integration (P0.01).It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer.In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration.The application of testing HPV genotyping and physical status based on detection of HC-Ⅱ HPV DNA would be in favor of predicting the progno-sis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.
The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.
Summary The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration ( P <0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.
Author 李科珍 金鑫 方勇 王常玉 龚妹 陈平波 刘佳 邓东锐 艾继辉
AuthorAffiliation Cancer
Author_xml – sequence: 1
  fullname: 李科珍 金鑫 方勇 王常玉 龚妹 陈平波 刘佳 邓东锐 艾继辉
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22282253$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtr3DAUhUVIaR7tD8gmGLpINm71lrUspnlAoIWG0p2Q5euJgi1NJDsl_z5KZgKhi1lJ6HznXnTOEdoPMQBCJwR_JRirb5kQoWWNCa0xJqpWe-iQaM1qwgTdL3epiqIYO0BHOd9jLJSk_CM6oJQ2lAp2iP62MSUY7exjqDqY_wGE6tfdU_bOjtXv2c5LruJQXS2TLYJd-3GMk63--FQEG_qqhfT4Crc2OR_iCgJknz-hD4MdM3zensfo9uLHbXtV3_y8vG6_39SOYz7XrHMdcUwqSySXnON-6EFTEFRyTERT3pRwrBOssxooNK6XcpBNEbWTgh2js83YdYoPC-TZTD47GEcbIC7ZaNIIJQjFhTzfSRJMccM1J7qgp1t06SbozTr5yaYn8xZbAdQGcCnmnGAwzs-vGc7J-rHMMi8FmU1BphRkXgoyqjjJf8634bs8dOPJhQ0rSOY-LimUVHeavmwX3cWweii-d5vKV7FSjWDPOXGsTw
CitedBy_id crossref_primary_10_1007_s11596_018_1868_3
crossref_primary_10_3390_pathogens9090685
crossref_primary_10_1016_j_envres_2020_109465
crossref_primary_10_1007_s10330_015_0092_x
crossref_primary_10_1158_1078_0432_CCR_12_1983
crossref_primary_10_1016_j_meegid_2018_03_003
crossref_primary_10_1007_s11596_013_1189_5
crossref_primary_10_1016_j_radonc_2013_06_004
crossref_primary_10_2174_1389557523666230213140641
crossref_primary_10_1038_s41598_025_93358_x
Cites_doi 10.2217/fvl.10.73
10.1128/JCM.44.5.1755-1762.2006
10.1099/jmm.0.019240-0
10.1158/1055-9965.EPI-09-0025
10.1038/sj.bjc.6602648
10.1158/0008-5472.CAN-07-6862
10.1158/0008-5472.CAN-04-0009
10.1128/JCM.44.4.1310-1317.2006
10.1128/JVI.02093-10
10.1002/path.2192
10.1016/j.vaccine.2008.06.021
10.1007/s00428-009-0823-x
10.1016/j.ygyno.2008.12.004
10.1038/sj.bjc.6601691
10.1016/j.jviromet.2009.01.005
10.1136/mp.53.4.201
10.1128/JCM.01212-08
10.1016/j.ygyno.2004.08.025
10.1128/JCM.35.3.791-795.1997
ContentType Journal Article
Copyright Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2012
Copyright_xml – notice: Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2012
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7U9
H94
7X8
DOI 10.1007/s11596-012-0017-7
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1993-1352
EndPage 102
ExternalDocumentID 22282253
10_1007_s11596_012_0017_7
1002007785
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJNI
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
DPUIP
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
ABQSL
H13
AAYXX
ADHKG
AGQPQ
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7U9
H94
7X8
ID FETCH-LOGICAL-c404t-3bcb1c367a1646440dfde92e5264015846475c3b53ba9e2e8cd66f684019c653
IEDL.DBID U2A
ISSN 1672-0733
IngestDate Fri Sep 05 10:39:02 EDT 2025
Fri Sep 05 05:58:42 EDT 2025
Thu Jan 02 23:11:22 EST 2025
Thu Apr 24 23:10:07 EDT 2025
Wed Oct 01 00:35:56 EDT 2025
Fri Feb 21 02:37:16 EST 2025
Wed Feb 14 10:42:25 EST 2024
IsPeerReviewed false
IsScholarly false
Issue 1
Keywords integration
physical status
human papilloma virus
cervical cancer
genotyping
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c404t-3bcb1c367a1646440dfde92e5264015846475c3b53ba9e2e8cd66f684019c653
Notes 42-1679/R
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 22282253
PQID 1020849419
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_918575120
proquest_miscellaneous_1020849419
pubmed_primary_22282253
crossref_citationtrail_10_1007_s11596_012_0017_7
crossref_primary_10_1007_s11596_012_0017_7
springer_journals_10_1007_s11596_012_0017_7
chongqing_primary_1002007785
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-02-01
PublicationDateYYYYMMDD 2012-02-01
PublicationDate_xml – month: 02
  year: 2012
  text: 2012-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: China
PublicationSubtitle Medical Sciences
PublicationTitle Journal of Huazhong University of Science and Technology. Medical sciences
PublicationTitleAbbrev J. Huazhong Univ. Sci. Technol. [Med. Sci.]
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Sciences
PublicationYear 2012
Publisher Huazhong University of Science and Technology
Publisher_xml – name: Huazhong University of Science and Technology
References Giuliano (CR19) 2008; 26
Jacobs, Snijders, Walboomers (CR9) 1997; 35
Michael, James, Jens (CR20) 2011; 85
Andersson, Safari, Mints (CR6) 2005; 92
CR13
Vonetta, Maria, Ubaldo (CR15) 2011; 6
Nambaru, Meenakumari, Swaminthan (CR17) 2009; 10
Graham, Herrington (CR12) 2000; 53
Boulet, Benoy, Depuydt (CR26) 2009; 18
Sathish, Abraham, Sridharan (CR25) 2004; 95
Cricca, Venturoli, Leo (CR23) 2009; 158
Yoshida, Sano, Oyama (CR22) 2009; 455
Kraus, Molden, Holm (CR10) 2006; 44
Rao, Wang, Fan (CR1) 2011; 40
Saunier, Monnier-Benoit, Mauny (CR24) 2008; 46
Shukla, Bharti, Mahata (CR21) 2010; 59
Moore, Chang (CR3) 2010; 10
Narisawa-Saito, Yoshimatsu, Ohno (CR5) 2008; 68
Matovina, Sabol, Grubišić (CR4) 2009; 113
Pett, Coleman (CR8) 2007; 212
Dong, Li, Wang (CR2) 2010; 39
Huang, Zhou, Xu (CR14) 2009; 13
Wentzensen, Vinokurova, Knebel (CR7) 2004; 64
Ding, Tian, Wu (CR16) 2010; 24
Kraus, Molden, Erno (CR11) 2004; 90
Arias-Pulido, Peyton, Joste (CR18) 2006; 44
M. Cricca (17_CR23) 2009; 158
J.L. Michael (17_CR20) 2011; 85
A.R. Giuliano (17_CR19) 2008; 26
17_CR13
T. Yoshida (17_CR22) 2009; 455
H. Arias-Pulido (17_CR18) 2006; 44
M. Narisawa-Saito (17_CR5) 2008; 68
N. Wentzensen (17_CR7) 2004; 64
G.A.V. Boulet (17_CR26) 2009; 18
H. Dong (17_CR2) 2010; 39
M.V. Jacobs (17_CR9) 1997; 35
Y.M. Rao (17_CR1) 2011; 40
I. Kraus (17_CR11) 2004; 90
S. Andersson (17_CR6) 2005; 92
W.C. Ding (17_CR16) 2010; 24
M. Saunier (17_CR24) 2008; 46
M.W. Vonetta (17_CR15) 2011; 6
P.S. Moore (17_CR3) 2010; 10
S. Shukla (17_CR21) 2010; 59
D.A. Graham (17_CR12) 2000; 53
M. Matovina (17_CR4) 2009; 113
B.Y. Huang (17_CR14) 2009; 13
N. Sathish (17_CR25) 2004; 95
I. Kraus (17_CR10) 2006; 44
M. Pett (17_CR8) 2007; 212
L. Nambaru (17_CR17) 2009; 10
18847554 - Vaccine. 2008 Aug 19;26 Suppl 10:K17-28
17573670 - J Pathol. 2007 Aug;212(4):356-67
16672403 - J Clin Microbiol. 2006 May;44(5):1755-62
16597856 - J Clin Microbiol. 2006 Apr;44(4):1310-7
15942630 - Br J Cancer. 2005 Jun 20;92(12):2195-200
15054464 - Br J Cancer. 2004 Apr 5;90(7):1407-13
19861526 - Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2992-9
18799702 - J Clin Microbiol. 2008 Nov;46(11):3678-85
21123375 - J Virol. 2011 Feb;85(4):1645-54
11040943 - Mol Pathol. 2000 Aug;53(4):201-6
15491758 - Gynecol Oncol. 2004 Nov;95(2):363-9
19727809 - Virchows Arch. 2009 Sep;455(3):253-9
20688948 - J Med Microbiol. 2010 Nov;59(Pt 11):1303-10
9041439 - J Clin Microbiol. 1997 Mar;35(3):791-5
19640172 - Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):355-60
15172997 - Cancer Res. 2004 Jun 1;64(11):3878-84
19187786 - J Virol Methods. 2009 Jun;158(1-2):180-3
21102637 - Nat Rev Cancer. 2010 Dec;10(12):878-89
19157528 - Gynecol Oncol. 2009 Apr;113(1):120-7
21318095 - Future Virol. 2011 Jan 1;6(1):45-57
18632622 - Cancer Res. 2008 Jul 15;68(14):5699-705
References_xml – volume: 6
  start-page: 45
  issue: 1
  year: 2011
  end-page: 57
  ident: CR15
  article-title: HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress
  publication-title: Future Virol
  doi: 10.2217/fvl.10.73
– volume: 10
  start-page: 355
  year: 2009
  end-page: 360
  ident: CR17
  article-title: Prognostic significance of HPV physical status and integration sites in cervical cancer
  publication-title: Asian Pacific J Cancer Prev
– volume: 44
  start-page: 1755
  issue: 5
  year: 2006
  end-page: 1762
  ident: CR18
  article-title: Human papillomavirus type 16 integration in cervical carcinoma , and in invasive cervical cancer
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.44.5.1755-1762.2006
– volume: 59
  start-page: 1303
  issue: Pt11
  year: 2010
  end-page: 1310
  ident: CR21
  article-title: Application of a multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses (HPVs) and typing of high-risk HPV types 16 and 18
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.019240-0
– volume: 18
  start-page: 2992
  issue: 11
  year: 2009
  end-page: 2999
  ident: CR26
  article-title: Human papillomavirus 16 load and E2/E6 ratio in HPV-16-positive women: biomarkers for cervical intraepithelial neoplasia ≥2 in a lLiquid-based cytology setting?
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-09-0025
– volume: 40
  start-page: 32
  issue: 1
  year: 2011
  end-page: 36
  ident: CR1
  article-title: Effects of MTA1 gene transfection on adhesion, migration and invasiveness of Hela cells by altered expression of MMP29 and β-catenin
  publication-title: Acta Med Univ Sci Technol Huazhong (Chinese)
– volume: 92
  start-page: 2195
  year: 2005
  end-page: 2200
  ident: CR6
  article-title: Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602648
– volume: 68
  start-page: 5699
  issue: 14
  year: 2008
  end-page: 5705
  ident: CR5
  article-title: An , multistep carcinogenesis model for human cervical cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6862
– volume: 64
  start-page: 3878
  issue: 11
  year: 2004
  end-page: 3884
  ident: CR7
  article-title: Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-0009
– volume: 44
  start-page: 1310
  issue: 4
  year: 2006
  end-page: 1317
  ident: CR10
  article-title: Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.44.4.1310-1317.2006
– volume: 85
  start-page: 1645
  issue: 4
  year: 2011
  end-page: 1654
  ident: CR20
  article-title: Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers
  publication-title: J Virol
  doi: 10.1128/JVI.02093-10
– volume: 212
  start-page: 356
  issue: 4
  year: 2007
  end-page: 367
  ident: CR8
  article-title: Integration of high-risk human papillomavirus: a key event in carcinogenesis?
  publication-title: J Pathol
  doi: 10.1002/path.2192
– volume: 39
  start-page: 254
  issue: 2
  year: 2010
  end-page: 257
  ident: CR2
  article-title: Comparison of the biological behaviors and prognostic factors in cervical adenocarcinoma and squamous carcinoma
  publication-title: Acta Med Univ Sci Technol Huazhong (Chinese)
– volume: 26
  start-page: K17
  issue: S10
  year: 2008
  end-page: K28
  ident: CR19
  article-title: Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.06.021
– volume: 455
  start-page: 253
  issue: 3
  year: 2009
  end-page: 259
  ident: CR22
  article-title: Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma
  publication-title: Virchows Arch
  doi: 10.1007/s00428-009-0823-x
– volume: 13
  start-page: 1065
  issue: 8
  year: 2009
  end-page: 1067
  ident: CR14
  article-title: Study on the detecting genotypes of human papillomavirus infection by using flow-through hybridization and gene chip
  publication-title: Chin J Lab Diagn (Chinese)
– volume: 24
  start-page: 3390
  year: 2010
  end-page: 3392
  ident: CR16
  article-title: Analysis on infection status of cervical human papillomavirus in 3753 women
  publication-title: Zhongguo Fuyou Baojian (Chinese)
– volume: 113
  start-page: 120
  year: 2009
  end-page: 127
  ident: CR4
  article-title: Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2008.12.004
– volume: 90
  start-page: 1407
  issue: 7
  year: 2004
  end-page: 1413
  ident: CR11
  article-title: Human papillomavirus oncogenic expression in the dysplasticportic portio; an investigation of biopsies from 190 cervical cones
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6601691
– volume: 158
  start-page: 180
  issue: 1–2
  year: 2009
  end-page: 183
  ident: CR23
  article-title: Disruption of HPV-16 E1 and E2 genes in precancerous cervical lesions
  publication-title: J Virol Met
  doi: 10.1016/j.jviromet.2009.01.005
– volume: 35
  start-page: 791
  issue: 3
  year: 1997
  end-page: 795
  ident: CR9
  article-title: A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings
  publication-title: J Clin Microbiol
– volume: 53
  start-page: 201
  issue: 4
  year: 2000
  end-page: 206
  ident: CR12
  article-title: HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities
  publication-title: Mol Pathol
  doi: 10.1136/mp.53.4.201
– volume: 10
  start-page: 878
  issue: 12
  year: 2010
  end-page: 889
  ident: CR3
  article-title: Why do viruses cause cancer? Highlights of the first century of human tumor virology
  publication-title: Nature
– ident: CR13
– volume: 46
  start-page: 3678
  issue: 11
  year: 2008
  end-page: 3685
  ident: CR24
  article-title: Analysis of human papillomavirus type 16 (HPV-16) DNA load and physical state for identification of HPV-16-infected women with high-grade lesions or cervical carcinoma
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01212-08
– volume: 95
  start-page: 363
  issue: 2
  year: 2004
  end-page: 369
  ident: CR25
  article-title: E2 sequence variations of HPV-16 among patients with cervical neoplasia seen in the Indian subcontinent
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2004.08.025
– volume: 46
  start-page: 3678
  issue: 11
  year: 2008
  ident: 17_CR24
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01212-08
– volume: 26
  start-page: K17
  issue: S10
  year: 2008
  ident: 17_CR19
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.06.021
– volume: 44
  start-page: 1755
  issue: 5
  year: 2006
  ident: 17_CR18
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.44.5.1755-1762.2006
– volume: 90
  start-page: 1407
  issue: 7
  year: 2004
  ident: 17_CR11
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6601691
– volume: 113
  start-page: 120
  year: 2009
  ident: 17_CR4
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2008.12.004
– volume: 68
  start-page: 5699
  issue: 14
  year: 2008
  ident: 17_CR5
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6862
– volume: 44
  start-page: 1310
  issue: 4
  year: 2006
  ident: 17_CR10
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.44.4.1310-1317.2006
– volume: 92
  start-page: 2195
  year: 2005
  ident: 17_CR6
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602648
– volume: 10
  start-page: 355
  year: 2009
  ident: 17_CR17
  publication-title: Asian Pacific J Cancer Prev
– volume: 24
  start-page: 3390
  year: 2010
  ident: 17_CR16
  publication-title: Zhongguo Fuyou Baojian (Chinese)
– volume: 10
  start-page: 878
  issue: 12
  year: 2010
  ident: 17_CR3
  publication-title: Nature
– volume: 85
  start-page: 1645
  issue: 4
  year: 2011
  ident: 17_CR20
  publication-title: J Virol
  doi: 10.1128/JVI.02093-10
– volume: 35
  start-page: 791
  issue: 3
  year: 1997
  ident: 17_CR9
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.35.3.791-795.1997
– volume: 39
  start-page: 254
  issue: 2
  year: 2010
  ident: 17_CR2
  publication-title: Acta Med Univ Sci Technol Huazhong (Chinese)
– ident: 17_CR13
– volume: 40
  start-page: 32
  issue: 1
  year: 2011
  ident: 17_CR1
  publication-title: Acta Med Univ Sci Technol Huazhong (Chinese)
– volume: 6
  start-page: 45
  issue: 1
  year: 2011
  ident: 17_CR15
  publication-title: Future Virol
  doi: 10.2217/fvl.10.73
– volume: 18
  start-page: 2992
  issue: 11
  year: 2009
  ident: 17_CR26
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-09-0025
– volume: 53
  start-page: 201
  issue: 4
  year: 2000
  ident: 17_CR12
  publication-title: Mol Pathol
  doi: 10.1136/mp.53.4.201
– volume: 455
  start-page: 253
  issue: 3
  year: 2009
  ident: 17_CR22
  publication-title: Virchows Arch
  doi: 10.1007/s00428-009-0823-x
– volume: 158
  start-page: 180
  issue: 1–2
  year: 2009
  ident: 17_CR23
  publication-title: J Virol Met
  doi: 10.1016/j.jviromet.2009.01.005
– volume: 64
  start-page: 3878
  issue: 11
  year: 2004
  ident: 17_CR7
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-0009
– volume: 13
  start-page: 1065
  issue: 8
  year: 2009
  ident: 17_CR14
  publication-title: Chin J Lab Diagn (Chinese)
– volume: 59
  start-page: 1303
  issue: Pt11
  year: 2010
  ident: 17_CR21
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.019240-0
– volume: 212
  start-page: 356
  issue: 4
  year: 2007
  ident: 17_CR8
  publication-title: J Pathol
  doi: 10.1002/path.2192
– volume: 95
  start-page: 363
  issue: 2
  year: 2004
  ident: 17_CR25
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2004.08.025
– reference: 16597856 - J Clin Microbiol. 2006 Apr;44(4):1310-7
– reference: 16672403 - J Clin Microbiol. 2006 May;44(5):1755-62
– reference: 9041439 - J Clin Microbiol. 1997 Mar;35(3):791-5
– reference: 11040943 - Mol Pathol. 2000 Aug;53(4):201-6
– reference: 21318095 - Future Virol. 2011 Jan 1;6(1):45-57
– reference: 19727809 - Virchows Arch. 2009 Sep;455(3):253-9
– reference: 15172997 - Cancer Res. 2004 Jun 1;64(11):3878-84
– reference: 15942630 - Br J Cancer. 2005 Jun 20;92(12):2195-200
– reference: 15491758 - Gynecol Oncol. 2004 Nov;95(2):363-9
– reference: 17573670 - J Pathol. 2007 Aug;212(4):356-67
– reference: 20688948 - J Med Microbiol. 2010 Nov;59(Pt 11):1303-10
– reference: 19861526 - Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2992-9
– reference: 21102637 - Nat Rev Cancer. 2010 Dec;10(12):878-89
– reference: 19640172 - Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):355-60
– reference: 18847554 - Vaccine. 2008 Aug 19;26 Suppl 10:K17-28
– reference: 19157528 - Gynecol Oncol. 2009 Apr;113(1):120-7
– reference: 18799702 - J Clin Microbiol. 2008 Nov;46(11):3678-85
– reference: 19187786 - J Virol Methods. 2009 Jun;158(1-2):180-3
– reference: 15054464 - Br J Cancer. 2004 Apr 5;90(7):1407-13
– reference: 21123375 - J Virol. 2011 Feb;85(4):1645-54
– reference: 18632622 - Cancer Res. 2008 Jul 15;68(14):5699-705
SSID ssj0057624
Score 1.5587884
Snippet The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role...
Summary The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and...
The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the...
SourceID proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 97
SubjectTerms Adult
Aged
Biopsy
cancer;genotyping;physical
Carcinogenesis
Cervical cancer
Cervix
China
Female
Genotyping
human
Human papillomavirus
Human papillomavirus 16 - genetics
Human papillomavirus 16 - isolation & purification
Humans
Infection
Integration
Medicine
Medicine & Public Health
Middle Aged
papilloma
Papillomavirus Infections - diagnosis
Papillomavirus Infections - virology
Polymerase chain reaction
Precancerous Conditions - diagnosis
Precancerous Conditions - virology
Primers
Prognosis
Risk Factors
Statistics as Topic
status;integration
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - virology
virus;cervical
Title Correlation between Physical Status of Human Papilloma Virus and Cervical Carcinogenesis
URI http://lib.cqvip.com/qk/85740A/201201/1002007785.html
https://link.springer.com/article/10.1007/s11596-012-0017-7
https://www.ncbi.nlm.nih.gov/pubmed/22282253
https://www.proquest.com/docview/1020849419
https://www.proquest.com/docview/918575120
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1993-1352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0057624
  issn: 1672-0733
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1993-1352
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0057624
  issn: 1672-0733
  databaseCode: U2A
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT-MwEB4tICEuK94EWGQkTqBIie3YybFCsAjEnkAqp8hxHKhUktK0-_uZyaPViu2BcyZ25LFnvnhmvgG4kOiUBHoev-C28BHfhj46QeMHRhVCCFuEAdUOP_5Rd8_yfhgNuzruus9270OSjaVeFruh56W_X-43plWvwUZEbF64iZ_5oDe_iJ_bTrZKU1qlEH0o839DEKHCW1W-fuB0_zqmL2jzS6S0cUC32_CzQ45s0Kp6B364chc2H7vY-B4Mr6nRRpvaxrr0Kzbp1MCocGhes6pgTVc-NjGT0XhcvRv2dzTFB6bMmW3sBgpbajBUVq9kB0f1Pjzd3jxd3_ld3wTfykDOfJHZLLRCaUPkYVIGeZG7hLsIwQ96f0QcUkdWZJHITOK4i22uVEGsL2FiVSQOYL2sSncETOdJkEseKk60YzwxMVpDzaVTJoxdrjw4XaxfOmnpMYgFmS5AdRx5EPRLmtqOcpw6X4zTJVkyaSRFjVBynU61B5eLV5YDrhQ-7_WU4qmgUIcpXTWvUZ4HsUxkmHjAVsgkRIOFeCfw4LDV8WJGuhZDQyc8uOqVnnZnu179Ocffkj6BLd7sREqNOYX12XTufiHAmWVnsDH4_fJwc9Zs7E_bA_AO
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BVgIuvB-BAkbiBEqV2I6dHKuqZaHdnhZpOUWO47QrlmRpdjnw65lJnF1B2UPPmdiOx5754hl_A_BeolMS6HnCitsqRHwbh-gETRgZVQkhbBVHdHd4cq7GX-WXWTLz97jbIdt9CEl2lnp72Q09L_398rAzrfo27En8P-Ej2Dv89O30eDDAiKD7WrZKU2KlEEMw83-NEKXCZVNf_MQO_3ZN1_DmtVhp54JOHsB0GHyfefL9YL0qDuzvf3gdb_h1D-G-h6TssF9Dj-CWqx_DnYkPuj-B2RFV8Ohz5pjP62JLr19GN5LWLWsq1pX7Y0uznC8WzQ_Dfs2v8IGpS2Y7g4TClioX1c0FGdh5-xSmJ8fTo3HoCzKEVkZyFYrCFrEVShtiJZMyKqvSZdwliKoQViCUkTqxokhEYTLHXWpLpSqik4kzqxLxDEZ1U7sXwHSZRaXkseLEZ8Yzk6KZ1Vw6ZeLUlSqA_Y1a8mXPu0H0ynSyqtMkgGjQVG49lzmV1FjkWxZmms8c55Oy9nSuA_iweWXb4E7hd4P6c9xuFEMxtWvWLcrzKJWZjLMA2A6ZjPi1EEhFATzvl86mRzpvQwsqAvg4LIPcG41293Be3kj6LdwdTydn-dnn89NXcI93a4ryb_ZhtLpau9eIolbFG79r_gAvVQ40
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCa2DCh2Kdo93cemATttMGpLsmQfi3ZB92ixQwLkZsiy3AbIbDdO-vtL-pFg6HLY2bRkiBL5WSQ_AnyW6JQEeh6_4LbwEd-GPjpB4wdGFUIIW4QB1Q5f36irqfwxi2Z9n9NmyHYfQpJdTQOxNJWrszovzraFb-iF6U-Y-62Z1c_hhSSeBNzQU34-mGLE0l1XW6UpxVKIIaz5ryGIXOGuKm_vceq_ndQT5Pkkato6o_EB7Pcokp13aj-EZ658BXvXfZz8NcwuqOlGl-bG-lQsVvcqYVREtG5YVbC2Qx-rTT1fLKo_hj3Ml_jAlDmzrQ1BYUvNhsrqlmzivHkDk_G3ycWV3_dQ8K0M5MoXmc1CK5Q2RCQmZZAXuUu4ixAIIRJA9CF1ZEUWicwkjrvY5koVxAATJlZF4i2Myqp074HpPAlyyUPFiYKMJyZGy6i5dMqEscuVByeb9UvrjiqDGJHpMlTHkQfBsKSp7enHqQvGIt0SJ5NGUtQIJdrpVHvwZfPKdsCdwp8GPaV4QijsYUpXrRuU50EsExkmHrAdMglRYiH2CTx41-l4MyNdkaHREx58HZSe9ue82f05R_8l_RH2fl-O01_fb34ew0vebkrKmDmB0Wq5dqeIe1bZh3ZvPwK8F_Wi
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+between+Physical+Status+of+Human+Papilloma+Virus+and+Cervical+Carcinogenesis&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Li%2C+K&rft.au=Jin%2C+X&rft.au=Fang%2C+Y&rft.au=Wang%2C+C&rft.date=2012-02-01&rft.issn=1672-0733&rft.volume=32&rft.issue=1&rft.spage=97&rft.epage=102&rft_id=info:doi/10.1007%2Fs11596-012-0017-7&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg